- Home
- PDSB vs LVTX Comparison
PDSB vs LVTX Comparison
Compare PDSB & LVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PDSB
- LVTX
- Stock Information
- Founded
- PDSB 2005
- LVTX 2016
- Country
- PDSB United States
- LVTX Netherlands
- Employees
- PDSB N/A
- LVTX N/A
- Industry
- PDSB Biotechnology: Pharmaceutical Preparations
- LVTX Biotechnology: Pharmaceutical Preparations
- Sector
- PDSB Health Care
- LVTX Health Care
- Exchange
- PDSB Nasdaq
- LVTX Nasdaq
- Market Cap
- PDSB 48.0M
- LVTX 40.8M
- IPO Year
- PDSB N/A
- LVTX 2021
- Fundamental
- Price
- PDSB $0.96
- LVTX $1.60
- Analyst Decision
- PDSB Strong Buy
- LVTX Hold
- Analyst Count
- PDSB 2
- LVTX 4
- Target Price
- PDSB $10.00
- LVTX $1.58
- AVG Volume (30 Days)
- PDSB 510.9K
- LVTX 439.0K
- Earning Date
- PDSB 11-13-2025
- LVTX 08-13-2025
- Dividend Yield
- PDSB N/A
- LVTX N/A
- EPS Growth
- PDSB N/A
- LVTX N/A
- EPS
- PDSB N/A
- LVTX N/A
- Revenue
- PDSB N/A
- LVTX $4,990,000.00
- Revenue This Year
- PDSB N/A
- LVTX N/A
- Revenue Next Year
- PDSB N/A
- LVTX N/A
- P/E Ratio
- PDSB N/A
- LVTX N/A
- Revenue Growth
- PDSB N/A
- LVTX N/A
- 52 Week Low
- PDSB $0.85
- LVTX $0.85
- 52 Week High
- PDSB $3.79
- LVTX $2.09
- Technical
- Relative Strength Index (RSI)
- PDSB 28.87
- LVTX 58.95
- Support Level
- PDSB $1.00
- LVTX $1.53
- Resistance Level
- PDSB $1.05
- LVTX $1.64
- Average True Range (ATR)
- PDSB 0.05
- LVTX 0.05
- MACD
- PDSB -0.01
- LVTX 0.00
- Stochastic Oscillator
- PDSB 5.29
- LVTX 85.42
About PDSB PDS Biotechnology Corporation
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV isa clinical stage immuno-oncology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer. Company's pipeline include's products such as LAVA-1266, LAVA-1427, LAVA-1433, LAVA-1207, PF08046052, JNJ89853413.